Fellowship · Tampa, FL
Sponsored by University of South Florida Morsani College of Medicine
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Hye Chon
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · Hye Chon
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 323 citations · Hye Chon
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 587 citations · Ardeshir Hakam
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 346 citations · Ardeshir Hakam
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 127 citations · Ardeshir Hakam
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 148 citations · Hye Chon, Robert Wenham
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 85 citations · Hye Chon